← 返回中文导览OiOi 医疗学习 · OnCo 肿瘤知识探索原项目 OnCo ↗

Cancers·Philadelphia chromosome-like acute lymphoblastic leukaemia (Ph-like or BCR::ABL1-like ALL)

Countries and centresPhiladelphia chromosome-like acute lymphoblastic leukaemia (Ph-like or BCR::ABL1-like ALL)

Back to the Philadelphia chromosome-like acute lymphoblastic leukaemia hub →1 centre

Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.

Countries and centres

Every country →Coverage by country →

Cases by country

Cases by country · GLOBOCAN 2022

All countries →

No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.

Expert centres

Where the expertise is

Expert centres

53 centres in 22 countries · 0 with a trial for this cancer on record · second-opinion finder →

Choose a region from the globe in the header to mark centres near you.

53 centres


Memorial Sloan Kettering Cancer Center New York · cancer center	United States	NCI comprehensive	0	5,120	95,936	Comprehensive genomic profiling CAR-T cell therapy Digital pathology & AI	#1
Centre Léon Bérard Lyon · cancer center	France	none recorded	0	1,061	14,344	Comprehensive genomic profiling Small-molecule kinase inhibitors Immune checkpoint inhibitors	-
Oslo University Hospital, The Norwegian Radium Hospital Oslo · cancer center	Norway	none recorded	0	989	13,065	Targeted alpha therapy Radioligand therapy (beta emitters)TCR-T cell therapy Proton therapy +1	-
Institut Paoli-Calmettes Marseille · cancer center	France	none recorded	0	776	8,165	Allogeneic (off-the-shelf) cell therapy CAR-T cell therapy Comprehensive genomic profiling	-
Guangdong Provincial People's Hospital Guangzhou · hospital	China	none recorded	0	769	8,924	Small-molecule kinase inhibitors Comprehensive genomic profiling Immune checkpoint inhibitors	-
Fox Chase Cancer Center Philadelphia, PA · cancer center	United States	NCI comprehensive	0	768	13,099	Germline (hereditary) testing	-
Rutgers Cancer Institute of New Jersey New Brunswick, NJ · cancer center	United States	NCI comprehensive	0	743	7,880	Comprehensive genomic profiling TCR-T cell therapy Metabolic therapy: starving the tumour of a nutrient	-
Aichi Cancer Center Nagoya · cancer center	Japan	none recorded	0	736	9,618	Comprehensive genomic profiling	-
German Cancer Consortium (DKTK) Heidelberg · consortium	Germany	none recorded	0	673	12,640	Whole-exome & whole-genome sequencing Comprehensive genomic profiling	-
St. Jude Children's Research Hospital Memphis, TN · cancer center	United States	NCI comprehensive	0	627	8,335	Proton therapy Whole-exome & whole-genome sequencing CAR-T cell therapy Proton therapy machines: cyclotrons, synchrotrons and single-room systems	-
Osaka International Cancer Institute Osaka · cancer center	Japan	none recorded	0	625	4,133	Comprehensive genomic profiling Robotic & minimally invasive surgery	-
Children's Hospital of Philadelphia Philadelphia, PA · hospital	United States	none recorded	0	571	9,273	CAR-T cell therapy Proton therapy Germline (hereditary) testing	-
OHSU Knight Cancer Institute Portland, OR · cancer center	United States	NCI comprehensive	0	539	7,500	Small-molecule kinase inhibitors Functional (ex vivo) drug testing N-of-1 and rapid platform trials	-
Institut du Cancer Paris CARPEM, AP-HP Centre Paris · hospital	France	OECI accredited OECI Comprehensive Cancer Centre	0	518	8,716	Comprehensive genomic profiling	-
Ghent University Hospital / Cancer Research Institute Ghent Ghent · hospital	Belgium	none recorded	0	495	5,334	Comprehensive genomic profiling Immune checkpoint inhibitors Small-molecule kinase inhibitors	-

(showing the first 15)

These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Philadelphia chromosome-like acute lymphoblastic leukaemia but is thinly recorded here will look small.

Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.

Seeking a second opinion: ask your oncologist for a referral to a high-volume centre; most accept records and pathology by mail or telehealth. In the US, use the NCI's Find a Cancer Center tool or the nonprofit Cancer Commons, which navigates options for advanced cancers at no cost. The second-opinion finder explains how referral works in your country.